676 related articles for article (PubMed ID: 22149315)
1. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
2. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.
Coker M; Ucar SK; Simsek DG; Darcan S; Bak M; Can S
Ther Apher Dial; 2009 Apr; 13(2):121-8. PubMed ID: 19379151
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
Gordon BR; Saal SD
J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
6. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
McGowan MP
J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
[TBL] [Abstract][Full Text] [Related]
7. A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy.
Ertorer ME; Guvenc B; Haydardedeoglu B; Tekinturhan F
Ther Apher Dial; 2008 Oct; 12(5):396-400. PubMed ID: 18937724
[TBL] [Abstract][Full Text] [Related]
8. Is lipoprotein (a)-apheresis useful?
Bambauer R
Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
[TBL] [Abstract][Full Text] [Related]
9. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre.
Mickiewicz A; Borowiec-Wolna J; Bachorski W; Gilis-Malinowska N; Gałąska R; Raczak G; Chmara M; Wasąg B; Jaguszewski MJ; Fijałkowski M; Gruchała M
Cardiol J; 2019; 26(6):669-679. PubMed ID: 30234904
[TBL] [Abstract][Full Text] [Related]
10. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
[TBL] [Abstract][Full Text] [Related]
11. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
[TBL] [Abstract][Full Text] [Related]
12. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
Thiery J; Seidel D
Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
[TBL] [Abstract][Full Text] [Related]
13. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Schneidewind JM; Latza R
ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
[TBL] [Abstract][Full Text] [Related]
14. Early-onset plasmapheresis and LDL-apheresis provide better disease control for pediatric homozygous familial hypercholesterolemia than HMG-CoA reductase inhibitors and ameliorate atherosclerosis.
Dann EJ; Shamir R; Mashiach T; Shaoul R; Badian A; Stravets T; Kerzman Y; Finkelbaum S; Gaitini D; Lorber A; Bonstein L
Transfus Apher Sci; 2013 Oct; 49(2):268-77. PubMed ID: 23791799
[TBL] [Abstract][Full Text] [Related]
15. Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?
Schettler VJJ; Ringel J; Jacob S; Julius U; Klingel R; Heigl F; Roeseler E; Grützmacher P;
Atheroscler Suppl; 2017 Nov; 30():44-49. PubMed ID: 29096860
[TBL] [Abstract][Full Text] [Related]
16. Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia.
Taylan C; Schlune A; Meissner T; Ažukaitis K; Udink Ten Cate FE; Weber LT
J Clin Lipidol; 2016; 10(6):1303-1310. PubMed ID: 27919346
[TBL] [Abstract][Full Text] [Related]
17. [Effects of LDL-apheresis--more than reduction of cholesterol?].
Schettler V; Wieland E
Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636
[TBL] [Abstract][Full Text] [Related]
18. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
[TBL] [Abstract][Full Text] [Related]
19. [LDL apheresis: an update and overview. LDL apheresis in Sardinia, Italy (SMILDLa)].
Stefanutti C; Di Giacomo S; Morozzi C
G Ital Nefrol; 2012; 29 Suppl 54():S14-8. PubMed ID: 22388823
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ
Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
